These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11364623)

  • 1. DMP 266 trials recruiting, many cities -- protease inhibitor naive.
    James JS
    AIDS Treat News; 1997 Sep; (No 278):5-6. PubMed ID: 11364623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NNRTIs: a neglected class.
    Cadman J
    GMHC Treat Issues; 1998 Sep; 12(9):6-10. PubMed ID: 11365807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
    AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combination.
    James JS
    AIDS Treat News; 1998 Jul; (No 299):1-3. PubMed ID: 11365599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMP 266 and indinavir combination.
    AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
    Bacheler L; Jeffrey S; Hanna G; D'Aquila R; Wallace L; Logue K; Cordova B; Hertogs K; Larder B; Buckery R; Baker D; Gallagher K; Scarnati H; Tritch R; Rizzo C
    J Virol; 2001 Jun; 75(11):4999-5008. PubMed ID: 11333879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination study for children.
    Vazquez E
    Posit Aware; 1998; 9(1):15. PubMed ID: 11364991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMP 266 on the horizon.
    Vazquez E
    Posit Aware; 1997; 8(5):25. PubMed ID: 11364636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776
    [No Abstract]   [Full Text] [Related]  

  • 10. What they say about non-nucleoside drugs.
    Posit Aware; 1999; 10(1):35-7. PubMed ID: 11366521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMP 266 now available.
    Gilden D
    GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded access programs.
    Treat Rev; 1997 Nov; (No 26-27):12. PubMed ID: 11364931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMP-266 and adefovir dipivoxil: 2 new AIDS drugs available to patients without treatment options.
    Baker R
    BETA; 1997 Sep; ():6-7. PubMed ID: 11364709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRIA clinical trials.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():59. PubMed ID: 11367496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
    Delaugerre C; Rohban R; Simon A; Mouroux M; Tricot C; Agher R; Huraux JM; Katlama C; Calvez V
    J Med Virol; 2001 Nov; 65(3):445-8. PubMed ID: 11596076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMP 266 (Sustiva) expanded access.
    Vazquez E; Whitfield L
    Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
    Lalezari JP; DeJesus E; Northfelt DW; Richmond G; Wolfe P; Haubrich R; Henry D; Powderly W; Becker S; Thompson M; Valentine F; Wright D; Carlson M; Riddler S; Haas FF; DeMasi R; Sista PR; Salgo M; Delehanty J
    Antivir Ther; 2003 Aug; 8(4):279-87. PubMed ID: 14518696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new and what's next.
    Fakuda D
    Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approves efavirenz. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.